Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-12
DOI
10.3389/fimmu.2017.00745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections
- (2017) Sabine Huenecke et al. Frontiers in Immunology
- Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
- (2017) Olaf Oberschmidt et al. Frontiers in Immunology
- Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection
- (2017) Silke Heidenreich et al. Frontiers in Immunology
- In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells
- (2017) Kattria van der Ploeg et al. Frontiers in Immunology
- Disarming Cellular Alarm Systems—Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses
- (2017) Dominik Schmiedel et al. Frontiers in Immunology
- Modeling Natural Killer Cell Targeted Immunotherapies
- (2017) Silvia Lopez-Lastra et al. Frontiers in Immunology
- The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development
- (2017) Mirte Post et al. Frontiers in Immunology
- Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation
- (2016) A. Mancusi et al. BLOOD
- High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
- (2016) John P. Veluchamy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A novel Flt3-deficient HIS mouse model with selective enhancement of human DC development
- (2016) Yan Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Relationship ofNKG2CCopy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets
- (2016) Aura Muntasell et al. JOURNAL OF IMMUNOLOGY
- Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells
- (2016) Dominik Schmiedel et al. JOURNAL OF VIROLOGY
- Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
- (2016) Angélica Cuapio et al. Oncotarget
- The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB
- (2016) Dominik Schmiedel et al. eLife
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
- (2016) John Pradeep Veluchamy et al. PLoS One
- Monoclonal antibodies in acute lymphoblastic leukemia
- (2015) E. Jabbour et al. BLOOD
- Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
- (2015) Markus Granzin et al. CYTOTHERAPY
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
- (2015) Chamutal Gur et al. IMMUNITY
- Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
- (2015) Zena Khaznadar et al. JOURNAL OF IMMUNOLOGY
- Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
- (2015) Julia D. Suerth et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Harnessing adaptive natural killer cells in cancer immunotherapy
- (2015) Lisa L. Liu et al. Molecular Oncology
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids
- (2015) Stephan Klöss et al. Frontiers in Immunology
- Increased sMICA and TGFβ1levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells
- (2015) Stephan Klöß et al. OncoImmunology
- Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia
- (2015) Anna Martner et al. OncoImmunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- A review of blinatumomab, a novel immunotherapy
- (2015) Matthew J Newman et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
- (2014) V. Bachanova et al. BLOOD
- CD19-CAR Trials
- (2014) Carlos A. Ramos et al. CANCER JOURNAL
- Development, Differentiation, and Diversity of Innate Lymphoid Cells
- (2014) Andreas Diefenbach et al. IMMUNITY
- Pharmacogenomics of cetuximab in metastatic colorectal carcinoma
- (2014) Nicola Silvestris et al. PHARMACOGENOMICS
- IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
- (2014) Dorit Lehmann et al. PLoS One
- Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction
- (2013) Aura Muntasell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
- (2012) Barbara Morandi et al. PLoS One
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Immune evasion of natural killer cells by viruses
- (2008) Stipan Jonjić et al. CURRENT OPINION IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started